These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31256128)
1. Mitophagy Failure in APP and Tau Overexpression Model of Alzheimer's Disease. Martín-Maestro P; Gargini R; García E; Simón D; Avila J; García-Escudero V J Alzheimers Dis; 2019; 70(2):525-540. PubMed ID: 31256128 [TBL] [Abstract][Full Text] [Related]
2. PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease. Martín-Maestro P; Gargini R; Perry G; Avila J; García-Escudero V Hum Mol Genet; 2016 Feb; 25(4):792-806. PubMed ID: 26721933 [TBL] [Abstract][Full Text] [Related]
3. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains. Vaillant-Beuchot L; Mary A; Pardossi-Piquard R; Bourgeois A; Lauritzen I; Eysert F; Kinoshita PF; Cazareth J; Badot C; Fragaki K; Bussiere R; Martin C; Mary R; Bauer C; Pagnotta S; Paquis-Flucklinger V; Buée-Scherrer V; Buée L; Lacas-Gervais S; Checler F; Chami M Acta Neuropathol; 2021 Jan; 141(1):39-65. PubMed ID: 33079262 [TBL] [Abstract][Full Text] [Related]
4. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease. Reddy PH; Oliver DM Cells; 2019 May; 8(5):. PubMed ID: 31121890 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer's disease. Medala VK; Gollapelli B; Dewanjee S; Ogunmokun G; Kandimalla R; Vallamkondu J J Neurosci Res; 2021 Apr; 99(4):1120-1135. PubMed ID: 33465841 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease. Hunter JM; Bowers WJ; Maarouf CL; Mastrangelo MA; Daugs ID; Kokjohn TA; Kalback WM; Luehrs DC; Valla J; Beach TG; Roher AE J Alzheimers Dis; 2011; 27(2):361-76. PubMed ID: 21860086 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial alterations in fibroblasts from sporadic Alzheimer's disease (AD) patients correlate with AD-related clinical hallmarks. Eysert F; Kinoshita PF; Lagarde J; Lacas-Gervais S; Xicota L; Dorothée G; Bottlaender M; Checler F; Potier MC; Sarazin M; Chami M Acta Neuropathol Commun; 2024 Jun; 12(1):90. PubMed ID: 38851733 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease. Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483 [TBL] [Abstract][Full Text] [Related]
9. Study of mitophagy and ATP-related metabolomics based on β-amyloid levels in Alzheimer's disease. Xiong X; Li S; Han TL; Zhou F; Zhang X; Tian M; Tang L; Li Y Exp Cell Res; 2020 Nov; 396(1):112266. PubMed ID: 32905804 [TBL] [Abstract][Full Text] [Related]
10. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971 [TBL] [Abstract][Full Text] [Related]
11. Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease. Tajima Y; Ishikawa M; Maekawa K; Murayama M; Senoo Y; Nishimaki-Mogami T; Nakanishi H; Ikeda K; Arita M; Taguchi R; Okuno A; Mikawa R; Niida S; Takikawa O; Saito Y Lipids Health Dis; 2013 May; 12():68. PubMed ID: 23659495 [TBL] [Abstract][Full Text] [Related]
13. RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity. Manczak M; Reddy PH Biochim Biophys Acta; 2013 Dec; 1832(12):2368-78. PubMed ID: 24063855 [TBL] [Abstract][Full Text] [Related]
14. Mitophagy in APPsw/PS1dE9 transgenic mice and APPsw stably expressing in HEK293 cells. Wang X; Zhao XL; Xu LL; Wang CF; Wei LF; Liu Z; Yang H; Wang P; Xie ZH; Bi JZ Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4595-602. PubMed ID: 26698257 [TBL] [Abstract][Full Text] [Related]
15. Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin. Hu Y; Li XC; Wang ZH; Luo Y; Zhang X; Liu XP; Feng Q; Wang Q; Yue Z; Chen Z; Ye K; Wang JZ; Liu GP Oncotarget; 2016 Apr; 7(14):17356-68. PubMed ID: 26943044 [TBL] [Abstract][Full Text] [Related]
16. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease. Song M; Zhao X; Song F Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222 [TBL] [Abstract][Full Text] [Related]
17. Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease. Reddy PH; Yin X; Manczak M; Kumar S; Pradeepkiran JA; Vijayan M; Reddy AP Hum Mol Genet; 2018 Jul; 27(14):2502-2516. PubMed ID: 29701781 [TBL] [Abstract][Full Text] [Related]
18. [Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease]. Mal'tsev AV; Davidchenko NV; Uteshev VK; Sokolik VV; Shtang OM; Iakushun MA; Sokolova NM; Suprin AK; Galzitskaia OV Biomed Khim; 2013; 59(2):144-70. PubMed ID: 23789343 [TBL] [Abstract][Full Text] [Related]
19. Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches. Mary A; Eysert F; Checler F; Chami M Mol Psychiatry; 2023 Jan; 28(1):202-216. PubMed ID: 35665766 [TBL] [Abstract][Full Text] [Related]